SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-082344
Filing Date
2023-11-02
Accepted
2023-11-01 20:15:50
Documents
13
Period of Report
2023-11-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea187618-8k_bluewater.htm   iXBRL 8-K 23202
2 PRESS RELEASE, DATED NOVEMBER 2, 2023 ea187618ex99-1_bluewater.htm EX-99.1 9686
  Complete submission text file 0001213900-23-082344.txt   210901

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bwv-20231102.xsd EX-101.SCH 3012
4 XBRL LABEL FILE bwv-20231102_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bwv-20231102_pre.xml EX-101.PRE 22358
7 EXTRACTED XBRL INSTANCE DOCUMENT ea187618-8k_bluewater_htm.xml XML 3426
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231369671
SIC: 2834 Pharmaceutical Preparations